Nimesh A. Patel, MD, explains why myopia-related retinal detachments are appearing earlier and how routine exams can catch ...
Cathleen McCabe, MD, presents real-world data from a 57-site US study of the enVista Aspire IOL at ESCRS 2026, reporting over ...
Tarcocimab, tabirafusp-ted were noninferior to aflibercept in DAYBREAK wet AMD trial; 54% on tarcocimab reached 24-week dosing.
Steve Swalgen is national director of lab business, Santinelli International, Hauppauge, NY. Swalgen also is an advisory board member of the Optical Laboratory Association (OLA) and has developed and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results